ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 039,46
-1,10%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Akebia Therapeutics Inc (AKBA)

  7. Akebia Therapeutics Inc (AKBA) Actualités

AKBA Akebia Therapeutics Inc

1,3303
0,0003 (0,02%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Akebia Therapeutics Inc AKBA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0003 0,02% 1,3303 01:10:40
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,32 1,29 1,35 1,34 1,33
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/4/202422:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
28/3/202401:26PRNUSAkebia Receives FDA Approval of Vafseo® (vadadustat) Tablets..
14/3/202421:15PRNUSAkebia Therapeutics Reports Fourth Quarter and Full Year..
11/3/202422:05PRNUSAkebia Therapeutics to Report Fourth Quarter and Full Year..
01/3/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
01/3/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:32EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:28EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:27EDGAR2Form 144 - Report of proposed sale of securities
28/2/202400:19EDGAR2Form 144 - Report of proposed sale of securities
28/2/202400:14EDGAR2Form 144 - Report of proposed sale of securities
28/2/202400:11EDGAR2Form 144 - Report of proposed sale of securities
13/2/202414:00EDGAR2Form 8-K - Current report
02/2/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
01/2/202422:52EDGAR2Form 144 - Report of proposed sale of securities
30/1/202422:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/1/202414:05EDGAR2Form 8-K - Current report
30/1/202414:00PRNUSAkebia Secures $55 Million Term Loan Financing
18/1/202423:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202414:30PRNUSAkebia Therapeutics Announces Appointment of Nicholas Grund..
08/1/202422:08EDGAR2Form 8-K - Current report
08/1/202414:02EDGAR2Form 8-K - Current report
02/1/202422:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
20/12/202314:00PRNUSAkebia Therapeutics to Present at the 42nd Annual J.P...
18/12/202322:07EDGAR2Form 8-K - Current report
01/12/202322:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
21/11/202323:07EDGAR2Form 8-K - Current report
20/11/202314:00PRNUSAkebia Therapeutics to Present at Piper Sandler Healthcare..
08/11/202313:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202313:33EDGAR2Form 8-K - Current report
08/11/202313:30PRNUSAkebia Therapeutics Reports Third Quarter 2023 Financial..
02/11/202321:34EDGAR2Form 8-K - Current report
02/11/202321:30PRNUSAkebia Therapeutics Announces Favorable Payment Term..
01/11/202321:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
31/10/202313:00PRNUSAkebia Therapeutics to Report Third Quarter 2023 Financial..
25/10/202322:06EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
AKBA
Akebia Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés